pamidronate has been researched along with Ectopic Ossification in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In all five patients, ranging from 47 to 68 years of age, we used continuous pamidronate infusions perioperatively at a dosage of 120 mg in the first 12 h and subsequent reduction to 75-60-30-15 mg/12 h over a period of 10-14 days." | 2.71 | Amino-bisphosphonates in heterotopic ossification: first experience in five consecutive cases. ( Christ-Crain, M; Dick, W; Haas, H; Mueller, B; Schuetz, P, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paparo, F | 1 |
| Parodi, M | 1 |
| Revelli, M | 1 |
| Ferrero, G | 1 |
| Garlaschi, G | 1 |
| Cimmino, MA | 1 |
| Wilkinson, JM | 1 |
| Stockley, I | 1 |
| Hamer, AJ | 1 |
| Barrington, NA | 1 |
| Eastell, R | 1 |
| Schuetz, P | 1 |
| Mueller, B | 1 |
| Christ-Crain, M | 1 |
| Dick, W | 1 |
| Haas, H | 1 |
| Hou, JW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study Into the Effect of Pamidronate for the Prevention of Heterotopic Ossification in High-risk Patients: A Randomized Controlled Trial[NCT00262392] | 0 participants (Actual) | Interventional | 2005-06-30 | Withdrawn | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for pamidronate and Ectopic Ossification
| Article | Year |
|---|---|
Biochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthroplasty, Replacement, Hip; Biomarkers; Bone Resorption; | 2003 |
Amino-bisphosphonates in heterotopic ossification: first experience in five consecutive cases.
Topics: Aged; Anti-Inflammatory Agents; Bone Density Conservation Agents; Diphosphonates; Drug Administratio | 2005 |
2 other studies available for pamidronate and Ectopic Ossification
| Article | Year |
|---|---|
Osteitis condensans of the sternal manubrium and ossification of the costoclavicular ligaments.
Topics: Anti-Inflammatory Agents; Diphosphonates; Drug Therapy, Combination; Female; Humans; Hyperostosis, S | 2012 |
Progressive osseous heteroplasia controlled by intravenous administration of pamidronate.
Topics: Adult; Bone Density Conservation Agents; Child, Preschool; Chromogranins; Diphosphonates; Disease Pr | 2006 |